WallStreetZenWallStreetZen

NASDAQ: MDCX
Medicus Pharma Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MDCX

Based on 2 analysts offering 12 month price targets for Medicus Pharma Ltd

Min Forecast
$20.00+706.45%
Avg Forecast
$23.50+847.58%
Max Forecast
$27.00+988.71%

Should I buy or sell MDCX stock?

Based on 2 analysts offering ratings for Medicus Pharma Ltd.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MDCX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MDCX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their MDCX stock forecasts and price targets.

MDCX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-29
lockedlocked$00.00+00.00%2025-05-08

1 of 1

Forecast return on equity

Is MDCX forecast to generate an efficient return?

Company
-82.26%
Industry
-2,124.31%
Market
-63.97%
MDCX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MDCX forecast to generate an efficient return on assets?

Company
-22.39%
Industry
23.08%
MDCX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MDCX earnings per share forecast

What is MDCX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.56
Avg 2 year Forecast
-$1.48
Avg 3 year Forecast
-$0.92

MDCX revenue forecast

What is MDCX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$72.2M
Avg 2 year Forecast
$144.6M
Avg 3 year Forecast
$366.4M

MDCX vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
MDCX$2.48$23.50+847.58%Strong Buy
MIRA$1.26N/AN/A
SCLX$14.93N/AN/A
AMRN$18.23$12.00-34.17%Strong Sell
OGN$9.60$14.00+45.83%Buy
View Top General Drug Manufacturer Stocks

Medicus Pharma Stock Forecast FAQ

Is Medicus Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MDCX) stock is to Strong Buy MDCX stock.

Out of 2 analysts, 2 (100%) are recommending MDCX as a Strong Buy, 0 (0%) are recommending MDCX as a Buy, 0 (0%) are recommending MDCX as a Hold, 0 (0%) are recommending MDCX as a Sell, and 0 (0%) are recommending MDCX as a Strong Sell.

If you're new to stock investing, here's how to buy Medicus Pharma stock.

What is MDCX's earnings growth forecast for 2025-2027?

(NASDAQ: MDCX) Medicus Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 32.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.46%.

Medicus Pharma's earnings in 2025 is -$16,512,289.On average, 2 Wall Street analysts forecast MDCX's earnings for 2025 to be -$27,704,294, with the lowest MDCX earnings forecast at -$30,109,490, and the highest MDCX earnings forecast at -$25,299,098. On average, 2 Wall Street analysts forecast MDCX's earnings for 2026 to be -$26,368,074, with the lowest MDCX earnings forecast at -$31,178,466, and the highest MDCX earnings forecast at -$21,557,682.

In 2027, MDCX is forecast to generate -$16,390,965 in earnings, with the lowest earnings forecast at -$16,390,965 and the highest earnings forecast at -$16,390,965.

What is MDCX's revenue growth forecast for 2028-2030?

(NASDAQ: MDCX) Medicus Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.

Medicus Pharma's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast MDCX's revenue for 2028 to be $1,286,690,731, with the lowest MDCX revenue forecast at $1,286,690,731, and the highest MDCX revenue forecast at $1,286,690,731. On average, 1 Wall Street analysts forecast MDCX's revenue for 2029 to be $2,575,875,738, with the lowest MDCX revenue forecast at $2,575,875,738, and the highest MDCX revenue forecast at $2,575,875,738.

In 2030, MDCX is forecast to generate $6,527,523,537 in revenue, with the lowest revenue forecast at $6,527,523,537 and the highest revenue forecast at $6,527,523,537.

What is MDCX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: MDCX) forecast ROA is -22.39%, which is lower than the forecast US Drug Manufacturers - General industry average of 23.08%.

What is MDCX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MDCX price target, the average MDCX price target is $23.50, with the highest MDCX stock price forecast at $27.00 and the lowest MDCX stock price forecast at $20.00.

On average, Wall Street analysts predict that Medicus Pharma's share price could reach $23.50 by Sep 29, 2026. The average Medicus Pharma stock price prediction forecasts a potential upside of 847.58% from the current MDCX share price of $2.48.

What is MDCX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: MDCX) Medicus Pharma's current Earnings Per Share (EPS) is -$1.34. On average, analysts forecast that MDCX's EPS will be -$1.56 for 2025, with the lowest EPS forecast at -$1.69, and the highest EPS forecast at -$1.42. On average, analysts forecast that MDCX's EPS will be -$1.48 for 2026, with the lowest EPS forecast at -$1.75, and the highest EPS forecast at -$1.21. In 2027, MDCX's EPS is forecast to hit -$0.92 (min: -$0.92, max: -$0.92).

What is MDCX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: MDCX) forecast ROE is -82.26%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.